Astec LifeSciences share news and announcements
NSE: ASTECBSE: 533138Fertilizers & AgrochemicalsSmall Cap
Last close ₹663.70down ₹5.50 (0.82%)BSE ₹664.30
Share price at the NSE close on 23 Oct 2026. Previous close ₹669.20.
52-week range of traded prices to 23 Oct 2026
₹513.40Low, 23 Mar 2026₹941.75High, 26 Nov 2025
- Next results date: the board meets on 26 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,479 Cr1,284th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 Apr 2026
- 3.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Jul 2026
- −21.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Jul 2026
- −4.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Apr 2026
- 1.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 33,48432.9% delivered
Astec LifeSciences share news and announcements
801 announcements, routine notices left out, newest first. Page 14 of 17.
Jan 2016
Dec 2015
Nov 2015
26 Nov · Disclosure of Voting Pattern - Clause 35A
Oct 2015
13 Oct · Board meeting
Sep 2015
24 Sep · Disclosure of Voting Pattern - Clause 35A
Aug 2015
Jul 2015
May 2015
16 May · Dividend
Board of Directors of the Company at its meeting held on May 16, 2015, has recommend enhanced dividend of Rs.1.25/- per share (i.e. 12.50% on the face value of Rs 10/- each) for the period ended March 31, 2015 for the approval of the Shareholders at the ensuing Annual General Meeting as compared to Re 1/- per share (i.e.10% on the face value of Rs 10/- each) which was declared for the previous year.
Mar 2015
2 Mar · Board meeting
To transact the following business: 1. Re-appointment of Mr. Ashok V. Hiremath as Managing Director subject to the approval of members. 2. Re-appointment of Mr. Janak Rawal as Whole Time Director subject to the approval of members. 3. Any other business with the permission of Chair.
Feb 2015
Jan 2015
21 Jan · Board meeting
Inter alia, to consider following business: 1) to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2014, after these results are reviewed by the Audit Committee, in terms of the provisions of clause 41 of the Listing Agreement and; 2) to consider allotment of 9,25,925 Equity Shares of Rs. 10/- each fully paid-up at Rs. 108/ - per share (including a premium of Rs. 98/- per share) on preferential basis to select persons/entities belonging to Non-Promoter Group, consequent to the approval of shareholders of the Company through Postal Ballot on January 20, 2015. Private placement offer letter is being sent to the select persons/entities belonging to Non-Promoter Group, as approved by Shareholders of the Company by passing of Special Resolution through Postal Ballot on January 20, 2015. 3) Any other matter with the permission of Chair.
Dec 2014
11 Dec · Board meeting
To consider and approve following items of agenda: 1) To consider and approve the issue and allotment of Equity shares on Preferential basis of Rs.10,00,00,000/- (Rupees Ten Crores Only) including premium thereon, to select persons/entities on such terms and conditions and at such price not lower than the price to be determined by SEBI (ICDR) Regulations, subject to the approval of members. 2) To approve the borrowing limits of the Company in compliance with the provisions of Section 180(1)(c) of the Companies Act, 2013. 3) To approve creation of charges on the assets of the Company in compliance with the provisions of Section 180(1)(a) of the Companies Act, 2013. 4) To grant Employee Stock Options to the employees of subsidiary companies of Astec LifeSciences Limited in compliance with terms and conditions of ESOP Scheme 2012, subject to the approval of members. 5) To authorize Director of the Company or Company Secretary to obtain the approval of members by way of conducting Postal ballot for item nos. 1, 2, 3 & 4 above. 6) Any other matter with the permission of Chair.
Oct 2014
8 Oct · Board meeting
To consider and approve amongst other items of agenda , the Unaudited Financial Results of the Company for the quarter ended September 30, 2014 after these results are reviewed by the Audit Committee. Further the Company's Code of Conduct for (Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the securities of the Company will be closed for the purpose of declaration of unaudited financial results of the Company for the quarter ended September 30, 2014 for all the Officers and Designated Employees (including Directors) of the Company from October 09, 2014 till 24 hours after the announcement of the financial results of the Company to the Stock Exchanges (both days inclusive). Accordingly all Officers and Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of Trading Window.
Sep 2014
Aug 2014
11 Aug · Updates
Company has fixed Cut-off date as August 22, 2014 for the purpose of dispatch of Annual Reports to the shareholders and for the purpose of Evoting.11 Aug · Board meeting
Board of Directors at its meeting held on August 9, 2014, has: 1. Approved increase of Authorised Share Capital from Rs. 20,00,00,000/- ( Rupees Twenty Crores Only ) to Rs. 25,00,00,000/- ( Rupees Twenty five Crores Only ) by creation of Rs.5,00,00,000/- (Rupees Five Crores Only) dividend 50,00,000 ( Fifty Lakhs ) Equity Shares of Rs. 10/- ( Rupees Ten Only ) each. 2. Approved Alteration of Memorandum of Association to give effect to point which shall be subject to shareholders approval. 3. Adopted new set of Memorandum and articles of Association to bring it on compliance with Companies Act 2013 subject to shareholders approval.11 Aug · Meeting
Company has fixed Book Closure from September 17, 2014 to September 23, 2014 ( both days inclusive ) for the purpose of Annual General Meeting scheduled to be held on September 23, 2014 and Dividend Payment.4 Aug · Board meeting
Inter-alia, to transact the following business: (1) To consider and approve the Unaudited financial accounts for the Quarter ended June 30, 2014, after these accounts are reviewed by Audit Committee.(2) To increase the Authorised Capital of the Company.(3) To alter Memorandum and Articles of Association of Company to give effect to item no.2 above.4 Aug · Updates
As per the Company's Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange board of India (Prohibition of insider Trading) Regulations, 1992, the Trading Window for dealing in the securities of the Company will be closed for the purpose of declaration of unaudited financial results of the Company for the quarter ended June 30, 2014 for all the officers and Designated Employees (including Directors) of the Company from August 5, 2014 till 24 hours after the announcement of the financial results of the Company to the Stock Exchanges (both days inclusive). Accordingly all officers and Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of Trading Window.
Jul 2014
Jun 2014
2 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2014,has recommend enhanced dividend of Rupee One per share (i.e. 10% on the face value of Rs. 10/- each) for the period ended March 31, 2014, for the approval of shareholders at the ensuing Annual General Meeting as compared to Seventy Five Paise per share (i.e. 7.5% on the face value of Rs. 10/- each) which was declared for the previous year.2 Jun · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2014, has accorded its consent to issuance of securities on preferential basis way of issue of Equity Shares/ Preference Shares/ Cumulative Convertible Bonds/ Debentures not exceeding Rupee 25 Crores (shall include premium thereon) at a price which shall be determined in accordance with the Guideline of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009.